Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATShares Issued
Ratios

ENDRA Life Sciences (NDRA) Long-Term Debt Issuances (2016 - 2019)

ENDRA Life Sciences (NDRA) has disclosed Long-Term Debt Issuances for 4 consecutive years, with $2.5 million as the latest value for Q3 2019.

  • Quarterly Long-Term Debt Issuances changed N/A to $2.5 million in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2020, changed 0.0% year-over-year, with the annual reading at $2.5 million for FY2019, 166.28% up from the prior year.
  • Long-Term Debt Issuances for Q3 2019 was $2.5 million at ENDRA Life Sciences, up from $935300.0 in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $2.5 million in Q3 2019, with the low at -$1.3 million in Q4 2016.
  • Average Long-Term Debt Issuances over 4 years is $616800.2, with a median of $580150.0 recorded in 2017.
  • Peak annual rise in Long-Term Debt Issuances hit 350.0% in 2017, while the deepest fall reached 350.0% in 2017.
  • Over 4 years, Long-Term Debt Issuances stood at -$1.3 million in 2016, then soared by 116.84% to $225000.0 in 2017, then surged by 315.69% to $935300.0 in 2018, then skyrocketed by 166.28% to $2.5 million in 2019.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods came in at $2.5 million, $935300.0, and $225000.0 for Q3 2019, Q2 2018, and Q1 2017 respectively.